Na-na Li

发表

Survey and Molecular Characterization of Drug- Resistant M. tuberculosis Clinical Isolates from Zunyi, Guizhou Province of China

Jianyong Zhang, Hong Zhang, Ling Chen, 2012 .

Genetic Diversity and Drug Susceptibility of Mycobacterium tuberculosis Isolates from Zunyi, One of the Highest-Incidence-Rate Areas in China

Jianyong Zhang, Hong Zhang, Ling Chen, 2011, Journal of Clinical Microbiology.

Transmission and drug-resistance of tuberculosis in Luodian revealed by whole genome sequencing based molecular epidemiology study

X. Liao, Q. Gao, T. Luo, 2020 .

A novel semiautomatic Chinese keywords instrument screening delirium based on electronic medical records

J. Yue, D. Xie, N. Ge, 2022, BMC Geriatrics.

Clinical efficacy and safety of Aidi injection plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: A meta-analysis of 31 randomized controlled trials following the PRISMA guidelines.

Xiaofan Chen, Yuan Jiang, Ji-Hong Feng, 2019, Journal of ethnopharmacology.

Has aidi injection the attenuation and synergistic efficacy to gemcitabine and cisplatin in non-small cell lung cancer? A meta-analysis of 36 randomized controlled trials

Qihai Gong, Ji-Hong Feng, Cheng-qiong Wang, 2016, Oncotarget.

Clinical Efficacy and Safety of Aidi Injection Plus Docetaxel-Based Chemotherapy in Advanced Nonsmall Cell Lung Cancer: A Meta-Analysis of 36 Randomized Controlled Trials

Qihai Gong, Ji-Hong Feng, Cheng-qiong Wang, 2018, Evidence-based complementary and alternative medicine : eCAM.

Can Aidi injection restore cellular immunity and improve clinical efficacy in non-small-cell lung cancer patients treated with platinum-based chemotherapy? A meta-analysis of 17 randomized controlled trials following the PRISMA guidelines

Hu Ma, Cheng-qiong Wang, Zheng Xiao, 2016, Medicine.

Can Aidi injection alleviate the toxicity and improve the clinical efficacy of radiotherapy in lung cancer?

Hu Ma, Shaofeng Xu, Cheng-qiong Wang, 2016, Medicine.

rpoB gene mutation profile in rifampicin-resistant Mycobacterium tuberculosis clinical isolates from Guizhou, one of the highest incidence rate regions in China.

Hong Zhang, Ling Chen, Na-na Li, 2010, The Journal of antimicrobial chemotherapy.

The Antitumor Immunity and Tumor Responses of Chemotherapy with or without DC-CIK for Non-Small-Cell Lung Cancer in China: A Meta-Analysis of 28 Randomized Controlled Trials

Xian-Tao Zeng, Ji-Hong Feng, Cheng-qiong Wang, 2018, Journal of immunology research.

Effectiveness and safety of chemotherapy with cytokine-induced killer cells in non-small cell lung cancer: A systematic review and meta-analysis of 32 randomized controlled trials.

Bin Ma, Ji-Hong Feng, Cheng-qiong Wang, 2019, Cytotherapy.

Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta‐analysis of 16 randomized controlled trials

Xian-Tao Zeng, Bin Ma, Song Yu, 2018, International immunopharmacology.

Multipleloci Variable-number Tandem Repeat Typing of Clinical Mycobacterium tuberculosis Isolates from Zunyi, Guizhou Province of China

Jianyong Zhang, Hong Zhang, Ling Chen, 2015 .

High prevalence of multidrug-resistant tuberculosis in Zunyi, Guizhou Province of China.

Jianyong Zhang, Hong Zhang, Ling Chen, 2011, The Journal of antimicrobial chemotherapy.

Antibiotic Susceptibility Patterns of Mycobacterium tuberculosis Isolates from Guizhou Province of China Against 13 Antituberculosis Drugs.

Hong Zhang, Ling Chen, Na-na Li, 2015, Microbial drug resistance.

Upward trends in new, rifampicin-resistant and concurrent extrapulmonary tuberculosis cases in northern Guizhou Province of China

D. Lei, Jianyong Zhang, Hong Zhang, 2021, Scientific reports.